133 related articles for article (PubMed ID: 27373582)
1. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.
Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I
Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582
[TBL] [Abstract][Full Text] [Related]
2. A comparison of case-finding strategies in the UK for the management of hip fractures.
Johansson H; Kanis JA; Oden A; Compston J; McCloskey E
Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810
[TBL] [Abstract][Full Text] [Related]
3. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
Azagra Ledesma R; Prieto-Alhambra D; Encabo Duró G; Casado Burgos E; Aguyé Batista A; Díez-Pérez A;
Med Clin (Barc); 2011 May; 136(14):613-9. PubMed ID: 21349558
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF Guidelines.
Kyriakos G; Vidal-Casariesgo A; Quiles-Sánchez LV; Urosa-Maggi JA; Calleja-Fernández A; Hernández-Moreno A; Ballesteros-Pomar MD; Cano-Rodriguez I
Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):466-473. PubMed ID: 27219881
[No Abstract] [Full Text] [Related]
6. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
[TBL] [Abstract][Full Text] [Related]
7. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
[TBL] [Abstract][Full Text] [Related]
8. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
[TBL] [Abstract][Full Text] [Related]
9. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
[TBL] [Abstract][Full Text] [Related]
10. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
Ni W; Jiang Y
Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
Silva DMW; Borba VZC; Kanis JA
Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
[TBL] [Abstract][Full Text] [Related]
12. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX.
Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2010 Mar; 21(3):495-505. PubMed ID: 19565175
[TBL] [Abstract][Full Text] [Related]
14. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
[TBL] [Abstract][Full Text] [Related]
17. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
[TBL] [Abstract][Full Text] [Related]
18. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
Carter M
J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
[TBL] [Abstract][Full Text] [Related]
20. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
